Naik Puja Appasaheb, Fleming Meghan Elizabeth, Bhatia Padam, Harden Cynthia L
Department of Neurology, Hofstra NSLIJ School of Medicine, 300 Community Drive, Manhasset, NY 11030, USA.
Zucker Hillside Hospital, 75-59 263rd Street, Glen Oaks, NY 11004, USA.
Epilepsy Behav. 2015 Jun;47:111-4. doi: 10.1016/j.yebeh.2015.04.016. Epub 2015 May 8.
We sought to understand the magnitude of the risk that drivers with epilepsy (DWE) contribute to motor vehicle accidents (MVAs) compared to other drivers.
We performed an evidence-based, systematic review using the American Academy of Neurology (AAN) guideline methodology.
Contributory evidence consisted of six Class II studies and one Class III study. Two articles reported a trend toward a decreased rate of overall MVA rates for DWE when compared with the general population with a relative risk (RR) of 0.86 (95% CI: 0.65-1.14) (Class III) and a RR of 1.00 (95% CI: 0.95-1.06) (Class II); both studies used patient report to ascertain MVA rates. Three Class II studies reported either a trend toward or an increased risk of MVA rates for DWE when compared with the general population with a RR of 1.62 (95% confidence interval (CI): 0.95-2.76), as ascertained by insurance, emergency department, and physician reporting databases, a RR of 1.73 (95% CI 1.58-1.90), as ascertained by police reports, and a RR of 7.01 (95% CI 2.18-26.13), as ascertained by casualty department visits. One Class II study showed that, compared to fatal crashes with DWE, fatal crashes were 26 times more likely to occur because of other medical conditions and 156 times more likely to occur because of alcohol abuse. Motor vehicle accident crashes due to seizures in DWE occurred in one out of every 2800 MVAs, as reported in another Class II study.
The evidence for the difference in MVA rates in DWE compared to the general population is inconsistent, and no conclusion can be made. Important methodological differences across the studies contribute to the imprecision. Future research should be performed using objective measures rather than self-reporting of MVAs by DWE and "miles driven" as the denominator to calculate MVA rates.
我们试图了解癫痫患者驾驶员(DWE)与其他驾驶员相比,导致机动车事故(MVA)的风险程度。
我们采用美国神经病学学会(AAN)指南方法进行了一项基于证据的系统评价。
有贡献的证据包括六项II级研究和一项III级研究。两篇文章报告,与普通人群相比,DWE的总体MVA发生率有下降趋势,相对风险(RR)为0.86(95%置信区间:0.65 - 1.14)(III级),RR为1.00(95%置信区间:0.95 - 1.06)(II级);两项研究均使用患者报告来确定MVA发生率。三项II级研究报告,与普通人群相比,DWE的MVA发生率有上升趋势或风险增加,RR为1.62(95%置信区间(CI):0.95 - 2.76),通过保险、急诊科和医生报告数据库确定;RR为1.73(95%置信区间:1.58 - 1.90),通过警方报告确定;RR为7.01(95%置信区间:2.18 - 26.13),通过伤亡部门就诊确定。一项II级研究表明,与DWE导致的致命撞车事故相比,因其他医疗状况导致的致命撞车事故发生可能性高26倍,因酗酒导致的致命撞车事故发生可能性高156倍。另一项II级研究报告称,DWE因癫痫发作导致的机动车事故撞车事故每2800起MVA中发生1起。
与普通人群相比,DWE的MVA发生率差异的证据不一致,无法得出结论。各项研究中重要的方法学差异导致了不精确性。未来的研究应使用客观测量方法,而不是由DWE自我报告MVA情况,并以“行驶里程”作为分母来计算MVA发生率。